Skip to main content
VCbacked
Log inGet Started

Amethyst Radiotherapy

Compiègne, France

Amethyst Radiotherapy operates radiotherapy clinics that provide advanced radiation therapy services for cancer treatment.

$322.2M raised
Jun 2024
Debt Financing
Health CareHealth DiagnosticsHospital

Top Investors

Ares ManagementAccession Capital PartnersThe Rohatyn Group

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Amethyst Radiotherapy

How much funding has Amethyst Radiotherapy raised?
Amethyst Radiotherapy has raised $322.2M in total funding. The most recent round was Debt Financing. The last funding was announced in June 2024.
Who are Amethyst Radiotherapy's investors?
Amethyst Radiotherapy's investors include Ares Management, Accession Capital Partners, The Rohatyn Group.
Where is Amethyst Radiotherapy headquartered?
Amethyst Radiotherapy is headquartered in Compiègne, France.
What does Amethyst Radiotherapy do?
Amethyst Radiotherapy operates radiotherapy clinics that provide advanced radiation therapy services for cancer treatment.
What stage is Amethyst Radiotherapy at?
Amethyst Radiotherapy is at the Debt Financing stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Amethyst Radiotherapy — Funding & Investors." VCBacked, June 11, 2024, https://www.vcbacked.co/company/amethyst-radiotherapy. Accessed July 1, 2026.
APA
VCBacked. (2024). Amethyst Radiotherapy — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/amethyst-radiotherapy
Wikipedia (cite web)
{{cite web |title=Amethyst Radiotherapy — Funding & Investors |url=https://www.vcbacked.co/company/amethyst-radiotherapy |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
OncoRevive
Brunswick$119K
Oryl Photonics
Lausanne
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
YLAH
Bern$589K
Novostia
Epalinges$6.6M